Operating Margin: 16.00%
Is the operating margin high or low?
The operating margin of 16.00% is 39% below its 5-year average of 26.03%, around the middle of its 5-year range (4.67%–34.79%).
As of Saturday, June 27, 2026. 2.32% below its 12-month average of 16.38%.
NRC Operating Margin
Reported quarterly operating margin; no daily interpolation.
NRC Average Operating Margin Chart
NRC Current vs Average Operating Margin Chart
NRC Operating Margin Metrics
OPERATING MARGIN
16.00%
OPERATING MARGIN AVG TTM
16.38%
OPERATING MARGIN AVG 3Y
25.40%
OPERATING MARGIN AVG 5Y
27.83%
OPERATING MARGIN AVG 10Y
29.56%
OPERATING MARGIN AVG 15Y
28.47%
OPERATING MARGIN AVG 20Y
26.86%
CURRENT VS TTM AVG
-2.32%
CURRENT VS 3Y AVG
-37.01%
CURRENT VS 5Y AVG
-42.50%
CURRENT VS 10Y AVG
-45.86%
CURRENT VS 15Y AVG
-43.80%
CURRENT VS 20Y AVG
-40.42%
NRC Competitors' Operating Margin
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 16.00% | 16.38% | 25.40% | 27.83% |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | -57.48% | -50.96% | -52.76% | -52.76% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -126.72% | -136.51% | -118.68% | -103.43% |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | -7.60% | -25.06% | -156.73% | -114.38% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 5.87% | -8.16% | -10.59% | -4.68% |
| TransMedics Group, Inc. (TMDX)vs › | $2.33B | 14.85% | 13.21% | -4.78% | -42.05% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.56B | 1.32% | 4.35% | -1.93% | -10.04% |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | 0.08% | -1.39% | -5.39% | -20.02% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.00B | 9.25% | 10.48% | 12.70% | 14.08% |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 11.50% | 11.05% | 9.46% | 10.06% |
Operating Efficiency
Gross Margin
55.9%
Operating Margin
16.0%
Operating Margin Formula & Definition
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Operating Margin FAQ
- What is the operating margin for National Research Corporation (NRC)?
- The operating margin for NRC stock is 16.00%.
- Is National Research Corporation's operating margin high or low?
- The operating margin of 16.00% is 39% below its 5-year average of 26.03%, around the middle of its 5-year range (4.67%–34.79%).
- What is the TTM average operating margin for National Research Corporation (NRC)?
- The TTM average operating margin for NRC stock is 16.38%.
- What is the 3Y average operating margin for National Research Corporation (NRC)?
- The 3Y average operating margin for NRC stock is 25.40%.
- What is the 5Y average operating margin for National Research Corporation (NRC)?
- The 5Y average operating margin for NRC stock is 27.83%.
- What is the 10Y average operating margin for National Research Corporation (NRC)?
- The 10Y average operating margin for NRC stock is 29.56%.
- What is the 15Y average operating margin for National Research Corporation (NRC)?
- The 15Y average operating margin for NRC stock is 28.47%.
- What is the 20Y average operating margin for National Research Corporation (NRC)?
- The 20Y average operating margin for NRC stock is 26.86%.
NRC Operating Margin History
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 16.00% |
| 2025-12-31 | 13.26% |
| 2025-09-30 | 22.36% |
| 2025-06-30 | 4.67% |
| 2025-03-31 | 25.62% |
| 2024-12-31 | 25.98% |
| 2024-09-30 | 22.28% |
| 2024-06-30 | 25.31% |
| 2024-03-31 | 24.81% |
| 2023-12-31 | 30.81% |
| 2023-09-30 | 26.24% |
| 2023-06-30 | 25.90% |
| 2023-03-31 | 24.72% |
| 2022-12-31 | 32.09% |
| 2022-09-30 | 29.47% |
| 2022-06-30 | 30.83% |
| 2022-03-31 | 30.43% |
| 2021-12-31 | 33.62% |
| 2021-09-30 | 34.79% |
| 2021-06-30 | 33.60% |
| 2021-03-31 | 33.89% |
| 2020-12-31 | 29.29% |
| 2020-09-30 | 35.91% |
| 2020-06-30 | 29.76% |
| 2020-03-31 | 33.06% |
| 2019-12-31 | 36.67% |
| 2019-09-30 | 31.48% |
| 2019-06-30 | 32.31% |
| 2019-03-31 | 34.00% |
| 2018-12-31 | 30.66% |
| 2018-09-30 | 30.54% |
| 2018-06-30 | 27.68% |
| 2018-03-31 | 28.88% |
| 2017-12-31 | 28.97% |
| 2017-09-30 | 24.60% |
| 2017-06-30 | 29.72% |
| 2017-03-31 | 32.98% |
| 2016-12-31 | 31.14% |
| 2016-09-30 | 27.15% |
| 2016-06-30 | 26.87% |
| 2016-03-31 | 28.73% |
| 2015-12-31 | 29.23% |
| 2015-09-30 | 25.94% |
| 2015-06-30 | 26.01% |
| 2015-03-31 | 22.19% |
| 2014-12-31 | 25.55% |
| 2014-09-30 | 30.23% |
| 2014-06-30 | 26.32% |
| 2014-03-31 | 32.27% |
| 2013-12-31 | 26.29% |
| 2013-09-30 | 26.91% |
| 2013-06-30 | 24.76% |
| 2013-03-31 | 28.98% |
| 2012-12-31 | 26.25% |
| 2012-09-30 | 26.41% |
| 2012-06-30 | 25.28% |
| 2012-03-31 | 27.14% |
| 2011-12-31 | 26.21% |
| 2011-09-30 | 22.61% |
| 2011-06-30 | 20.92% |
| 2011-03-31 | 28.80% |
| 2010-12-31 | 14.85% |
| 2010-09-30 | 21.82% |
| 2010-06-30 | 18.80% |
| 2010-03-31 | 30.78% |
| 2009-12-31 | 24.01% |
| 2009-09-30 | 24.40% |
| 2009-06-30 | 19.88% |
| 2009-03-31 | 26.13% |
| 2008-12-31 | 24.39% |
| 2008-09-30 | 23.44% |
| 2008-06-30 | 21.49% |
| 2008-03-31 | 24.54% |
| 2007-12-31 | 16.82% |
| 2007-09-30 | 29.46% |
| 2007-06-30 | 22.65% |
| 2007-03-31 | 22.36% |
| 2006-12-31 | 18.17% |
| 2006-09-30 | 29.98% |
| 2006-06-30 | 20.08% |
| 2006-03-31 | 20.05% |
| 2005-12-31 | 27.07% |
| 2005-09-30 | 32.84% |
| 2005-06-30 | 21.45% |
| 2005-03-31 | 18.77% |
| 2004-12-31 | 21.89% |
| 2004-09-30 | 29.86% |
| 2004-06-30 | 20.65% |
| 2004-03-31 | 25.06% |
| 2003-12-31 | 28.34% |
| 2003-09-30 | 26.23% |
| 2003-06-30 | 23.59% |
| 2003-03-31 | 24.96% |
| 2002-12-31 | 32.17% |
| 2002-09-30 | 31.81% |
| 2002-06-30 | 31.55% |
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green